Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Dengue virus can infect human hair follicle cells and may cause hair loss.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Effective treatment significantly improves pododermatitis in dogs, reducing symptoms and extending remission.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.